RU2002103305A - Пуриновые производные как ингибиторы тирозинпротеинеиназы SYK - Google Patents
Пуриновые производные как ингибиторы тирозинпротеинеиназы SYKInfo
- Publication number
- RU2002103305A RU2002103305A RU2002103305/04A RU2002103305A RU2002103305A RU 2002103305 A RU2002103305 A RU 2002103305A RU 2002103305/04 A RU2002103305/04 A RU 2002103305/04A RU 2002103305 A RU2002103305 A RU 2002103305A RU 2002103305 A RU2002103305 A RU 2002103305A
- Authority
- RU
- Russia
- Prior art keywords
- alkyl
- group
- formula
- purine
- oxygen
- Prior art date
Links
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 title 1
- 229940019748 antifibrinolytic proteinase inhibitors Drugs 0.000 title 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 title 1
- 229940083251 peripheral vasodilators purine derivative Drugs 0.000 title 1
- 125000000561 purinyl group Chemical class N1=C(N=C2N=CNC2=C1)* 0.000 title 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 claims 9
- 229910052739 hydrogen Inorganic materials 0.000 claims 7
- 239000001257 hydrogen Substances 0.000 claims 7
- 229910052757 nitrogen Inorganic materials 0.000 claims 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 4
- PXBRQCKWGAHEHS-UHFFFAOYSA-N dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 claims 4
- 125000000623 heterocyclic group Chemical group 0.000 claims 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 4
- 229910052760 oxygen Inorganic materials 0.000 claims 4
- 239000001301 oxygen Substances 0.000 claims 4
- 125000006413 ring segment Chemical group 0.000 claims 4
- 229910052717 sulfur Inorganic materials 0.000 claims 4
- CYRMSUTZVYGINF-UHFFFAOYSA-N trichlorofluoromethane Chemical compound FC(Cl)(Cl)Cl CYRMSUTZVYGINF-UHFFFAOYSA-N 0.000 claims 4
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 3
- 125000003545 alkoxy group Chemical group 0.000 claims 3
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 3
- 125000005078 alkoxycarbonylalkyl group Chemical group 0.000 claims 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 3
- 125000004181 carboxyalkyl group Chemical group 0.000 claims 3
- 150000001875 compounds Chemical class 0.000 claims 3
- 125000005842 heteroatom Chemical group 0.000 claims 3
- 150000002431 hydrogen Chemical class 0.000 claims 3
- 239000011593 sulfur Chemical group 0.000 claims 3
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 claims 2
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims 2
- 125000004432 carbon atom Chemical group C* 0.000 claims 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 2
- 125000001188 haloalkyl group Chemical group 0.000 claims 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 2
- 150000003839 salts Chemical group 0.000 claims 2
- 125000001424 substituent group Chemical group 0.000 claims 2
- AIHKUUPSBZMBLI-UHFFFAOYSA-N 2-n,6-n-diphenyl-7h-purine-2,6-diamine Chemical compound N=1C(NC=2C=CC=CC=2)=C2NC=NC2=NC=1NC1=CC=CC=C1 AIHKUUPSBZMBLI-UHFFFAOYSA-N 0.000 claims 1
- HEZLWTWBGFAUCF-UHFFFAOYSA-N 2-n-(4-methylphenyl)-6-n-phenyl-7h-purine-2,6-diamine Chemical compound C1=CC(C)=CC=C1NC1=NC(NC=2C=CC=CC=2)=C(NC=N2)C2=N1 HEZLWTWBGFAUCF-UHFFFAOYSA-N 0.000 claims 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims 1
- 125000003342 alkenyl group Chemical group 0.000 claims 1
- 125000003710 aryl alkyl group Chemical group 0.000 claims 1
- -1 benzocycloalkyl Chemical group 0.000 claims 1
- 125000002837 carbocyclic group Chemical group 0.000 claims 1
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 1
- LFIVVGZLCOQRQH-UHFFFAOYSA-N n-(4-butylphenyl)-6-methoxy-7h-purin-2-amine Chemical compound C1=CC(CCCC)=CC=C1NC1=NC(OC)=C(NC=N2)C2=N1 LFIVVGZLCOQRQH-UHFFFAOYSA-N 0.000 claims 1
- KZOFMVLEQMEJEU-UHFFFAOYSA-N n-(4-butylphenyl)-6-methylsulfanyl-7h-purin-2-amine Chemical compound C1=CC(CCCC)=CC=C1NC1=NC(SC)=C(NC=N2)C2=N1 KZOFMVLEQMEJEU-UHFFFAOYSA-N 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 125000004434 sulfur atom Chemical group 0.000 claims 1
Claims (2)
1. Соединение формулы
в свободной форме или в форме соли,
где Х означает атом кислорода или серы или группу NR5;
R1 означает алкильную, алкенильную, циклоалкильную, бензоциклоалкильную, циклоалкилалкильную или аралкильную группу, которая необязательно может быть замещена гидрокси, алкокси, карбокси или алкоксикарбонилом или, когда Х означает NR5, альтернативно R1 может означать гетероциклильную группу или группу формулы
R2, R3, R4, R6, R7 и R8 означают каждый независимо друг от друга водород, галоид, алкил, галоидалкил, алкокси, карбокси, алкоксикарбонил, карбоксиалкил, алкоксикарбонилалкил, -N(R9)R10, -SO2N(R11)R12, (C1-C4)алкилен-SO2N(R11)R12 или -CON(R13)R14 или, когда два заместителя из R2, R3 и R4 или два заместителя из R6, R7 и R8 присоединены к смежным атомам углерода в указанных бензольных кольцах, то вместе с углеродными атомами, к которым они присоединены, они означают карбоциклическую группу, содержащую 5-10 кольцевых атомов, или гетероциклическую группу, содержащую 5-10 кольцевых атомов, из которых один, два или три означают гетероатомы, выбранные из азота, кислорода и серы;
R5 означает водород или алкил;
R9 означает водород или алкил;
R10 означает водород, алкил или -COR15, где R15 означает алкил, галоидалкил, алкокси, алкоксиалкил, алкоксикарбонил, карбоксиалкил или алкоксикарбонилалкил, или R9 и R10 означают вместе с атомом азота, к которому они присоединены, гетероциклическую группу, содержащую 5 или 6 кольцевых атомов, из которых один или два означают гетероатомы, выбранные из азота, кислорода или серы,
R11 означает водород или алкил;
R12 означает водород, алкил, гидроксиалкил, алкоксиалкил, карбоксиалкил или алкоксикарбонилалкил, или R11 и R12 означают вместе с атомом азота, к которому они присоединены, гетероциклическую группу, содержащую 5 или 6 кольцевых атомов, из которых один или два означают гетероатомы, выбранные из азота, кислорода и серы;
R13 и R14 означают каждый независимо друг от друга водород или алкил;
за исключением 2-(пара-н-бутиланилино)-6-метоксипурина, 2-(пара-н-бутиланилино)-6-(метилтио)пурина, 2,6-ди(фениламино)пурина, 2,6-ди(пара-толиламино)пурина и 2-(пара-толиламино)-6-(фениламино)пурина.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9918035.8A GB9918035D0 (en) | 1999-07-30 | 1999-07-30 | Organic compounds |
GB9918035.8 | 1999-07-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2002103305A true RU2002103305A (ru) | 2003-09-10 |
RU2248977C2 RU2248977C2 (ru) | 2005-03-27 |
Family
ID=10858317
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2002103305/04A RU2248977C2 (ru) | 1999-07-30 | 2000-07-28 | Пуриновые производные как ингибиторы тирозинпротеиназы syk |
Country Status (33)
Country | Link |
---|---|
US (1) | US6589950B1 (ru) |
EP (1) | EP1200435B1 (ru) |
JP (2) | JP2003506375A (ru) |
KR (1) | KR100485289B1 (ru) |
CN (1) | CN1213047C (ru) |
AR (1) | AR029175A1 (ru) |
AT (1) | ATE251160T1 (ru) |
AU (1) | AU767349B2 (ru) |
BR (1) | BR0012888A (ru) |
CA (1) | CA2379560C (ru) |
CO (1) | CO5180626A1 (ru) |
CZ (1) | CZ2002299A3 (ru) |
DE (1) | DE60005684T2 (ru) |
DK (1) | DK1200435T3 (ru) |
EC (1) | ECSP003589A (ru) |
ES (1) | ES2208395T3 (ru) |
GB (1) | GB9918035D0 (ru) |
HK (1) | HK1046679A1 (ru) |
HU (1) | HUP0201935A3 (ru) |
IL (1) | IL147455A0 (ru) |
MX (1) | MXPA02001102A (ru) |
MY (1) | MY126862A (ru) |
NO (1) | NO20020467L (ru) |
NZ (1) | NZ516667A (ru) |
PE (1) | PE20010543A1 (ru) |
PL (1) | PL354477A1 (ru) |
PT (1) | PT1200435E (ru) |
RU (1) | RU2248977C2 (ru) |
SK (1) | SK285730B6 (ru) |
TR (1) | TR200200234T2 (ru) |
TW (2) | TWI255268B (ru) |
WO (1) | WO2001009134A1 (ru) |
ZA (1) | ZA200200783B (ru) |
Families Citing this family (110)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1941501A (en) * | 1999-11-30 | 2001-06-12 | Parker Hughes Institute | Syk localized at centrosome |
FR2802091A1 (fr) * | 1999-12-08 | 2001-06-15 | Oreal | Compositions pour la teinture des fibres keratiniques contenant des derives de paraphenylenediamine a groupement azetidinyle |
CN1474815A (zh) | 2000-09-20 | 2004-02-11 | Ĭ��ר���ɷ�����˾ | 4-氨基-喹唑啉 |
ES2324981T3 (es) | 2000-12-21 | 2009-08-21 | Smithkline Beecham Corporation | Pirimidinaminas como moduladores de la angiogenesis. |
GB0101686D0 (en) * | 2001-01-23 | 2001-03-07 | Cancer Res Campaign Tech | Cyclin dependent kinase inhibitors |
US7829566B2 (en) | 2001-09-17 | 2010-11-09 | Werner Mederski | 4-amino-quinazolines |
WO2003031406A2 (en) * | 2001-10-12 | 2003-04-17 | Irm Llc | Kinase inhibitor scaffolds and methods for their preparation |
US20030158195A1 (en) | 2001-12-21 | 2003-08-21 | Cywin Charles L. | 1,6 naphthyridines useful as inhibitors of SYK kinase |
EP1465900B1 (en) | 2002-01-10 | 2008-05-14 | Bayer HealthCare AG | Rho-kinase inhibitors |
CA2473510A1 (en) | 2002-01-23 | 2003-07-31 | Bayer Pharmaceuticals Corporation | Pyrimidine derivatives as rho-kinase inhibitors |
ES2298497T3 (es) | 2002-01-23 | 2008-05-16 | Bayer Pharmaceuticals Corporation | Inhibidores de quinasa rho. |
TWI329105B (en) | 2002-02-01 | 2010-08-21 | Rigel Pharmaceuticals Inc | 2,4-pyrimidinediamine compounds and their uses |
CA2475764C (en) * | 2002-03-13 | 2011-05-31 | Janssen Pharmaceutica N.V. | New inhibitors of histone deacetylase |
HK1080465A1 (zh) | 2002-03-13 | 2006-04-28 | Janssen Pharmaceutica N.V. | 作为组蛋白脱乙酰酶新颖抑制剂的磺酰基氨基衍生物 |
US6897307B2 (en) | 2002-03-28 | 2005-05-24 | Novartis Ag | Process for preparing 2,6-diaminopurine derivatives |
US6855724B2 (en) | 2002-04-08 | 2005-02-15 | Agouron Pharmaceuticals, Inc. | Tropane derivatives useful in therapy |
WO2003106416A2 (en) * | 2002-06-17 | 2003-12-24 | Smithkline Beecham Corporation | Chemical process |
HRP20050082A2 (en) * | 2002-07-19 | 2005-06-30 | Memory Pharmaceuticals Corporation | 6-amino-1h-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors |
MXPA05001096A (es) | 2002-07-29 | 2005-11-23 | Rigel Pharmaceuticals Inc | Metodos para tratamiento o prevencion de enfermedades autoinmunes con compuestos de 2,4-diamino-pirimidina. |
EP1444982A1 (de) * | 2003-02-06 | 2004-08-11 | Merckle Gmbh | Verwendung von Purinderivaten als selektive Kinase-Inhibitoren |
HRP20130602T1 (en) | 2003-07-30 | 2013-07-31 | Rigel Pharmaceuticals, Inc. | 2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases |
BRPI0413563A (pt) * | 2003-08-15 | 2006-10-17 | Irm Llc | compostos e composições como inibidores de atividade do receptor de quìnase de tirosina |
KR20060121878A (ko) * | 2003-09-25 | 2006-11-29 | 얀센 파마슈티카 엔.브이. | Hiv를 저해하는 퓨린 유도체 |
AU2004288715A1 (en) * | 2003-11-06 | 2005-05-26 | Celgene Corporation | Methods of using and compositions comprising a JNK inhibitor for the treatment and management of asbestos-related diseases and disorders |
US7951592B2 (en) | 2003-11-10 | 2011-05-31 | The Scripps Research Institute | Compositions and methods for inducing cell dedifferentiation |
GB0407723D0 (en) * | 2004-04-05 | 2004-05-12 | Novartis Ag | Organic compounds |
US8057815B2 (en) * | 2004-04-19 | 2011-11-15 | Portola Pharmaceuticals, Inc. | Methods of treatment with Syk inhibitors |
WO2005118543A1 (ja) * | 2004-06-03 | 2005-12-15 | Ono Pharmaceutical Co., Ltd. | キナーゼ阻害薬およびその用途 |
US7439246B2 (en) | 2004-06-28 | 2008-10-21 | Bristol-Myers Squibb Company | Fused heterocyclic kinase inhibitors |
US20050288290A1 (en) * | 2004-06-28 | 2005-12-29 | Borzilleri Robert M | Fused heterocyclic kinase inhibitors |
US7709645B2 (en) * | 2004-07-27 | 2010-05-04 | Sgx Pharmaceuticals, Inc. | Pyrrolo-pyridine kinase modulators |
CA2573362A1 (en) | 2004-07-27 | 2006-02-09 | Sgx Pharmaceuticals, Inc. | Pyrrolo-pyridine kinase modulators |
US7361764B2 (en) * | 2004-07-27 | 2008-04-22 | Sgx Pharmaceuticals, Inc. | Pyrrolo-pyridine kinase modulators |
EP1778687A2 (en) | 2004-07-27 | 2007-05-02 | SGX Pharmaceuticals, Inc. | Fused ring heterocycle kinase modulators |
US7626021B2 (en) * | 2004-07-27 | 2009-12-01 | Sgx Pharmaceuticals, Inc. | Fused ring heterocycle kinase modulators |
WO2006010750A1 (en) | 2004-07-28 | 2006-02-02 | Janssen Pharmaceutica N.V. | Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase |
US20080027034A1 (en) * | 2004-09-10 | 2008-01-31 | Shah Tushar P | Ciclesonide and Syk Inhibitor Combination and Method of Use Thereof |
ATE540035T1 (de) | 2004-11-24 | 2012-01-15 | Rigel Pharmaceuticals Inc | Spiro-2,4-pyrimidindiamin-verbindungen und ihre verwendungen |
CN100526315C (zh) * | 2005-06-16 | 2009-08-12 | 浙江医药股份有限公司新昌制药厂 | N2-喹啉或异喹啉取代的嘌呤衍生物及其制备方法和其用途 |
WO2007042298A1 (en) * | 2005-10-13 | 2007-04-19 | Glaxo Group Limited | Pyrrolopyrimidine derivatives as syk inhibitors |
WO2007053776A1 (en) * | 2005-11-03 | 2007-05-10 | Sgx Pharmaceuticals, Inc. | Pyrimidinyl-thiophene kinase modulators |
WO2007070872A1 (en) | 2005-12-15 | 2007-06-21 | Rigel Pharmaceuticals, Inc. | Kinase inhibitors and their uses |
WO2007082882A1 (en) * | 2006-01-19 | 2007-07-26 | Janssen Pharmaceutica N.V. | Substituted indolyl-alkyl-amino-derivatives as inhibitors of histone deacetylase |
ATE432272T1 (de) * | 2006-01-19 | 2009-06-15 | Janssen Pharmaceutica Nv | Aminophenylderivate als neue inhibitoren von histondeacetylase |
WO2007082874A1 (en) | 2006-01-19 | 2007-07-26 | Janssen Pharmaceutica N.V. | Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase |
MX2008012482A (es) * | 2006-03-31 | 2008-10-10 | Abbott Lab | Compuestos de indazol. |
PL2084162T3 (pl) | 2006-10-23 | 2013-01-31 | Sgx Pharmaceuticals Inc | Bicykliczne triazole jako modulatory kinaz białkowych |
US20080139531A1 (en) * | 2006-12-04 | 2008-06-12 | Alcon Manufacturing Ltd. | Use of connective tissue mast cell stabilizers to facilitate ocular surface re-epithelization and wound repair |
EP2091918B1 (en) * | 2006-12-08 | 2014-08-27 | Irm Llc | Compounds and compositions as protein kinase inhibitors |
MY148427A (en) | 2006-12-08 | 2013-04-30 | Irm Llc | Compounds and compositions as protein kinase inhibitors |
WO2008081928A1 (ja) * | 2006-12-28 | 2008-07-10 | Taisho Pharmaceutical Co., Ltd. | ピラゾロピリミジン化合物 |
CA2683016A1 (en) | 2007-03-07 | 2008-09-12 | Boehringer Ingelheim International Gmbh | 9h- purine derivatives and their use in the treatment of proliferative diseases |
JP2010524858A (ja) | 2007-04-10 | 2010-07-22 | エスジーエックス ファーマシューティカルズ、インコーポレイテッド | 縮合環複素環キナーゼ調節因子 |
CN101289449A (zh) * | 2007-04-20 | 2008-10-22 | 浙江医药股份有限公司新昌制药厂 | 2,6-二含氮取代的嘌呤衍生物及其制备方法和应用 |
WO2008135232A1 (en) * | 2007-05-02 | 2008-11-13 | Riccardo Cortese | Use and compositions of purine derivatives for the treatment of proliferative disorders |
BRPI0812360A2 (pt) * | 2007-05-21 | 2015-01-27 | Sgx Pharmaceuticals Inc | Compostos moduladores de quinase heterocíclica e método de modulação da atividade de uma proteína tirosina quinase |
CL2008001540A1 (es) * | 2007-05-29 | 2009-05-22 | Sgx Pharmaceuticals Inc | Compuestos derivados de pirrolopiridinas y pirazolopiridinas; composicion farmaceutica; y uso en el tratamiento del cancer. |
US7705004B2 (en) | 2007-08-17 | 2010-04-27 | Portola Pharmaceuticals, Inc. | Protein kinase inhibitors |
FR2929851B1 (fr) * | 2008-04-09 | 2012-11-30 | Centre Nat Rech Scient | Molecules inhibant une voie metabolique impliquant la proteine tyrosine kinase syk et procede d'identification de ces molecules |
US8138339B2 (en) | 2008-04-16 | 2012-03-20 | Portola Pharmaceuticals, Inc. | Inhibitors of protein kinases |
NZ589315A (en) | 2008-04-16 | 2012-11-30 | Portola Pharm Inc | 2,6-diamino-pyrimidin-5-yl-carboxamides as Spleen tryosine kinase (syk) or Janus kinase (JAK) inhibitors |
BRPI0910668A2 (pt) * | 2008-04-22 | 2019-09-24 | Portola Pharmaceutiacals Inc | inibidores de proteína quinases |
FI2300013T4 (fi) | 2008-05-21 | 2025-02-04 | Takeda Pharmaceutical Company Limited | Fosforijohdannaisia kinaasin estäjinä |
US9273077B2 (en) | 2008-05-21 | 2016-03-01 | Ariad Pharmaceuticals, Inc. | Phosphorus derivatives as kinase inhibitors |
US20100029689A1 (en) * | 2008-07-02 | 2010-02-04 | Memory Pharmaceuticals Corporation | Phosphodiesterase 4 inhibitors |
WO2010111406A2 (en) * | 2009-03-24 | 2010-09-30 | Myriad Pharmaceuticals, Inc. | Compounds and therapeutic uses thereof |
US8759366B2 (en) * | 2009-12-17 | 2014-06-24 | Merck Sharp & Dohme Corp. | Aminopyrimidines as SYK inhibitors |
AU2010333804B2 (en) | 2009-12-23 | 2015-07-16 | Takeda Pharmaceutical Company Limited | Fused heteroaromatic pyrrolidinones as syk inhibitors |
WO2011153553A2 (en) | 2010-06-04 | 2011-12-08 | The Regents Of The University Of California | Methods and compositions for kinase inhibition |
EP2489663A1 (en) | 2011-02-16 | 2012-08-22 | Almirall, S.A. | Compounds as syk kinase inhibitors |
KR101884010B1 (ko) | 2011-05-04 | 2018-07-31 | 어리어드 파마슈티칼스, 인코포레이티드 | Egfr-유도된 암의 세포 증식을 억제하는 화합물 |
AU2012253885A1 (en) | 2011-05-10 | 2013-10-31 | Merck Sharp & Dohme Corp. | Aminopyrimidines as Syk inhibitors |
EP2707357B1 (en) | 2011-05-10 | 2017-01-18 | Merck Sharp & Dohme Corp. | Pyridyl aminopyridines as syk inhibitors |
EP2706852B1 (en) | 2011-05-10 | 2018-08-22 | Merck Sharp & Dohme Corp. | Bipyridylaminopyridines as syk inhibitors |
CA2837207A1 (en) | 2011-06-01 | 2012-12-06 | Janus Biotherapeutics, Inc. | Novel immune system modulators |
JP6026525B2 (ja) | 2011-06-22 | 2016-11-16 | 武田薬品工業株式会社 | 置換6−アザ−イソインドリン−1−オン誘導体 |
US9006444B2 (en) | 2011-10-05 | 2015-04-14 | Merck Sharp & Dohme Corp. | Phenyl carboxamide-containing spleen tyrosine kinase (SYK) inhibitors |
WO2013052394A1 (en) | 2011-10-05 | 2013-04-11 | Merck Sharp & Dohme Corp. | 2-pyridyl carboxamide-containing spleen tyrosine kinase (syk) inhibitors |
EP2763975B1 (en) | 2011-10-05 | 2016-04-06 | Merck Sharp & Dohme Corp. | 3-pyridyl carboxamide-containing spleen tyrosine kinase (syk) inhibitors |
AU2012340555B2 (en) | 2011-11-23 | 2016-10-20 | Portola Pharmaceuticals, Inc. | Pyrazine kinase inhibitors |
AR090650A1 (es) * | 2012-04-12 | 2014-11-26 | Alcon Res Ltd | Tratamiento para respuestas inflamatorias inducidas por microbios en el ojo |
JP6469567B2 (ja) | 2012-05-05 | 2019-02-13 | アリアド・ファーマシューティカルズ・インコーポレイテッド | Egfr発動性がんの細胞増殖阻害用化合物 |
WO2013192128A1 (en) | 2012-06-20 | 2013-12-27 | Merck Sharp & Dohme Corp. | Imidazolyl analogs as syk inhibitors |
US9242984B2 (en) | 2012-06-20 | 2016-01-26 | Merck Sharp & Dohme Corp. | Pyrazolyl derivatives as Syk inhibitors |
WO2013192088A1 (en) | 2012-06-22 | 2013-12-27 | Merck Sharp & Dohme Corp. | SUBSTITUTED DIAZINE AND TRIAZINE SPLEEN TYROSINE KINASE (Syk) INHIBITORS |
WO2013192098A1 (en) | 2012-06-22 | 2013-12-27 | Merck Sharp & Dohme Corp. | SUBSTITUTED PYRIDINE SPLEEN TYROSINE KINASE (Syk) INHIBITORS |
US9353066B2 (en) | 2012-08-20 | 2016-05-31 | Merck Sharp & Dohme Corp. | Substituted phenyl-Spleen Tyrosine Kinase (Syk) inhibitors |
US9586931B2 (en) | 2012-09-28 | 2017-03-07 | Merck Sharp & Dohme Corp. | Triazolyl derivatives as Syk inhibitors |
EP2931281B1 (en) | 2012-12-12 | 2018-01-17 | Merck Sharp & Dohme Corp. | Amino-pyrimidine-containing spleen tyrosine kinase inhibitors |
EP2934525B1 (en) | 2012-12-21 | 2019-05-08 | Merck Sharp & Dohme Corp. | Thiazole-substituted aminopyridines as spleen tyrosine kinase inhibitors |
US9611283B1 (en) | 2013-04-10 | 2017-04-04 | Ariad Pharmaceuticals, Inc. | Methods for inhibiting cell proliferation in ALK-driven cancers |
US9745295B2 (en) | 2013-04-26 | 2017-08-29 | Merck Sharp & Dohme Corp. | Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors |
EP2988749B1 (en) | 2013-04-26 | 2019-08-14 | Merck Sharp & Dohme Corp. | Thiazole-substituted aminopyrimidines as spleen tyrosine kinase inhibitors |
CN104418858B (zh) * | 2013-08-30 | 2018-12-11 | 浙江医药股份有限公司新昌制药厂 | 2,6-二含氮取代的嘌呤衍生物及其制备方法和其药物组合物与应用 |
US9783531B2 (en) | 2013-12-20 | 2017-10-10 | Merck Sharp & Dohme Corp. | Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors |
WO2015095445A1 (en) | 2013-12-20 | 2015-06-25 | Merck Sharp & Dohme Corp. | Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors |
WO2015095444A1 (en) | 2013-12-20 | 2015-06-25 | Merck Sharp & Dohme Corp. | Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors |
EP3116506B1 (en) | 2014-03-13 | 2019-04-17 | Merck Sharp & Dohme Corp. | 2-pyrazine carboxamides as spleen tyrosine kinase inhibitors |
EP3134405B1 (en) | 2014-04-25 | 2019-08-28 | Pfizer Inc | Heteroaromatic compounds and their use as dopamine d1 ligands |
RU2570113C1 (ru) * | 2014-12-08 | 2015-12-10 | Федеральное государственное бюджетное учреждение науки Институт органического синтеза им. И.Я. Постовского Уральского отделения Российской академии наук | N-(2-ацетамидопурин-6-ил)глицин, обладающий противотуберкулезной активностью |
WO2016130920A2 (en) * | 2015-02-13 | 2016-08-18 | Dana-Farber Cancer Institute, Inc. | Lrrk2 inhibitors and methods of making and using the same |
JP2018521089A (ja) * | 2015-07-24 | 2018-08-02 | グラクソ グループ リミテッドGlaxo Group Limited | 白斑の治療 |
WO2017181285A1 (en) | 2016-04-21 | 2017-10-26 | The Royal Institution For The Advancement Of Learning/Mcgill University | Purine compounds and method for the treatment of cancer |
IL266109B2 (en) * | 2016-10-21 | 2025-05-01 | Nimbus Lakshmi Inc | Tyk2 inhibitors and uses thereof |
CN111194319A (zh) | 2017-10-19 | 2020-05-22 | 拜耳动物保健有限责任公司 | 稠合的杂芳族吡咯烷酮类化合物用于治疗和预防动物中的疾病的用途 |
US12012408B2 (en) | 2018-06-22 | 2024-06-18 | The Royal Institution For The Advancement Of Learning/Mcgill University | Purine compounds and method for the treatment of cancer |
EP3894392A4 (en) | 2018-12-11 | 2022-08-24 | Duke University | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER |
CA3129665A1 (en) | 2019-03-21 | 2020-09-24 | Onxeo | A dbait molecule in combination with kinase inhibitor for the treatment of cancer |
JP2023500906A (ja) | 2019-11-08 | 2023-01-11 | インサーム(インスティテュ ナシオナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシェ メディカル) | キナーゼ阻害剤に対する獲得抵抗性を有するがんの処置方法 |
WO2021148581A1 (en) | 2020-01-22 | 2021-07-29 | Onxeo | Novel dbait molecule and its use |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3529497A1 (de) | 1985-08-17 | 1987-02-26 | Boehringer Mannheim Gmbh | N(pfeil hoch)6(pfeil hoch)-disubstituierte purinderivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel |
EP0626964A1 (en) * | 1992-02-19 | 1994-12-07 | Pfizer Inc. | Heterocyclic compounds for enhancing antitumor activity |
DK0633886T3 (da) * | 1992-04-03 | 2000-12-18 | Upjohn Co | Farmaceutisk aktive bicyclisk-heterocycliske aminer |
US5550132A (en) * | 1994-06-22 | 1996-08-27 | University Of North Carolina | Hydroxyalkylammonium-pyrimidines or purines and nucleoside derivatives, useful as inhibitors of inflammatory cytokines |
GB9417249D0 (en) * | 1994-08-26 | 1994-10-19 | Wellcome Found | A novel salt |
US7091346B1 (en) * | 1995-11-01 | 2006-08-15 | Novartis Ag | Purine derivatives and processes for their preparation |
US5866702A (en) * | 1996-08-02 | 1999-02-02 | Cv Therapeutics, Incorporation | Purine inhibitors of cyclin dependent kinase 2 |
WO1999007705A1 (en) * | 1997-08-07 | 1999-02-18 | The Regents Of The University Of California | Purine inhibitor of protein kinases, g proteins and polymerases |
GB9903762D0 (en) * | 1999-02-18 | 1999-04-14 | Novartis Ag | Organic compounds |
-
1999
- 1999-07-30 GB GBGB9918035.8A patent/GB9918035D0/en not_active Ceased
-
2000
- 2000-07-20 TW TW089114515A patent/TWI255268B/zh not_active IP Right Cessation
- 2000-07-20 TW TW94101835A patent/TWI274754B/zh not_active IP Right Cessation
- 2000-07-25 PE PE2000000744A patent/PE20010543A1/es not_active Application Discontinuation
- 2000-07-26 CO CO00056110A patent/CO5180626A1/es not_active Application Discontinuation
- 2000-07-27 EC EC2000003589A patent/ECSP003589A/es unknown
- 2000-07-27 AR ARP000103890A patent/AR029175A1/es unknown
- 2000-07-28 CA CA002379560A patent/CA2379560C/en not_active Expired - Fee Related
- 2000-07-28 EP EP00953112A patent/EP1200435B1/en not_active Expired - Lifetime
- 2000-07-28 PT PT00953112T patent/PT1200435E/pt unknown
- 2000-07-28 HK HK02107013.6A patent/HK1046679A1/zh unknown
- 2000-07-28 HU HU0201935A patent/HUP0201935A3/hu unknown
- 2000-07-28 TR TR2002/00234T patent/TR200200234T2/xx unknown
- 2000-07-28 AT AT00953112T patent/ATE251160T1/de not_active IP Right Cessation
- 2000-07-28 US US10/048,577 patent/US6589950B1/en not_active Expired - Lifetime
- 2000-07-28 WO PCT/EP2000/007311 patent/WO2001009134A1/en not_active Application Discontinuation
- 2000-07-28 DK DK00953112T patent/DK1200435T3/da active
- 2000-07-28 PL PL00354477A patent/PL354477A1/xx not_active Application Discontinuation
- 2000-07-28 MX MXPA02001102A patent/MXPA02001102A/es active IP Right Grant
- 2000-07-28 JP JP2001514337A patent/JP2003506375A/ja not_active Withdrawn
- 2000-07-28 MY MYPI20003444 patent/MY126862A/en unknown
- 2000-07-28 KR KR10-2002-7001276A patent/KR100485289B1/ko not_active Expired - Fee Related
- 2000-07-28 CN CNB008110263A patent/CN1213047C/zh not_active Expired - Fee Related
- 2000-07-28 SK SK126-2002A patent/SK285730B6/sk not_active IP Right Cessation
- 2000-07-28 AU AU65677/00A patent/AU767349B2/en not_active Ceased
- 2000-07-28 IL IL14745500A patent/IL147455A0/xx unknown
- 2000-07-28 RU RU2002103305/04A patent/RU2248977C2/ru not_active IP Right Cessation
- 2000-07-28 BR BR0012888-0A patent/BR0012888A/pt not_active Application Discontinuation
- 2000-07-28 CZ CZ2002299A patent/CZ2002299A3/cs unknown
- 2000-07-28 ES ES00953112T patent/ES2208395T3/es not_active Expired - Lifetime
- 2000-07-28 DE DE60005684T patent/DE60005684T2/de not_active Expired - Fee Related
- 2000-07-28 NZ NZ516667A patent/NZ516667A/en unknown
-
2002
- 2002-01-29 NO NO20020467A patent/NO20020467L/no not_active Application Discontinuation
- 2002-01-29 ZA ZA200200783A patent/ZA200200783B/en unknown
-
2007
- 2007-05-16 JP JP2007130684A patent/JP2007217426A/ja active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2002103305A (ru) | Пуриновые производные как ингибиторы тирозинпротеинеиназы SYK | |
RU2331643C2 (ru) | Пиразолопиримидины и средство, обладающее фунгицидной и бактерицидной активностью для борьбы с вредными организмами, на их основе | |
CO5180626A1 (es) | Derivados de purina inhibidores de proteina quinasa syk | |
RU2356891C2 (ru) | Производные пиридинкарбоксамида и их соли для применения в качестве инсектицида | |
PT1184376E (pt) | Novos derivados heterociclicos de carboxamida | |
PE20060531A1 (es) | Derivados de piridazin-3-(2h)-ona como inhibidores de la fosfodiesterasa 4 | |
RU2007139453A (ru) | Гетеробициклические ингибиторы вируса гепатита с (hcv) | |
ES2530431T3 (es) | Compuestos heterocíclicos como moduladores positivos del receptor de glutamato metabotrópico 2 (receptor mGlu2) | |
RU2001115829A (ru) | Дикетон в качестве промежуточного продукта при получении 3-галоген-1н-пиразолов | |
MY119238A (en) | 8-quinolinzanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitors | |
PT1140851E (pt) | 4-oxo-1,4-di-hidro-3-quinolinacarboxamidas como agentes antivirais | |
AR038536A1 (es) | N-aril-2-oxazolidinona-5- carboxamidas y sus derivados | |
ATE388146T1 (de) | 1-isopropyl-2-oxo-1,2-dihydropyridin-3- carbonsäureamidderivate mit agonistischer wirkung am 5-ht4-rezeptor | |
HUP0204429A2 (hu) | Aril-amin-származékok és alkalmazásuk antitelomeráz hatású szerként | |
ATE134630T1 (de) | Bizyklische pyran-derivate und ihre verwendung als 5-lipoxygenasehemmer | |
CO5251438A1 (es) | Derivados del acido hidroxamico sustituidos por arilsul- fonamido, compuestos y composiciones farmaceuticas que los contienen y procedimiento para su aplicacion y preparacion | |
RU2007147433A (ru) | Производные n-формилгидроксиламина | |
EA200600046A1 (ru) | Производные 6-[2-(фосфонометокси)алкокси]пиримидинов (варианты), способ их получения (варианты), фармацевтическая композиция на их основе и способ лечения вирусной инфекции | |
EP1357124A4 (en) | HETEROCYCLIC COMPOUNDS AND COMPOSITIONS IMPROVING CEREBRAL FUNCTIONS CONTAINING THESE AS ACTIVE INGREDIENTS | |
NO20053449L (no) | 3-substituerte 4-pyrimidonderivater | |
RU2004130284A (ru) | Антипаразитарные производные артемизинина (эндопероксиды) | |
DE3174787D1 (de) | Aroyl amino acids | |
ATE147073T1 (de) | Hydantoin-derivate | |
EA200501388A1 (ru) | 7-алкениламинотриазолопиримидины, способ их получения и их применение для борьбы с фитопатогенными грибами, а также содержащие их средства | |
DE60237652D1 (de) | Variolinderivate und ihre Verwendung als Cytostatika |